DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



The Effect of Perioperative Pregabalin on the Incidence of Chronic Post-thoracotomy Pain Syndrome

Information source: Queen's University
Information obtained from ClinicalTrials.gov on December 08, 2011
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Thoracic Surgery; Chronic Pain

Intervention: Pregabalin (Drug)

Phase: Phase 3

Status: Not yet recruiting

Sponsored by: Queen's University

Official(s) and/or principal investigator(s):
Jorge E Zamora, MD, Principal Investigator, Affiliation: Queen's University/ Kingston General Hospital

Overall contact:
Jorge E Zamora, MD, Phone: (613) 548-7827, Email: zamoraj@kgh.kair.net

Summary

Pregabalin, administered prior to and following lateral thoracotomy surgery will reduce the likelihood of chronic post-thoracotomy pain syndrome (CPTPS).

Clinical Details

Official title: A Multicenter Prospective Randomized Double-blind Placebo Controlled Trial Assessing the Effect of Perioperative Pregabalin on the Incidence of Chronic Post Thoracotomy Pain Syndrome

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Primary outcome: Incidence of chronic post thoracotomy pain syndrome

Secondary outcome: During hospital stay: pain intensity, PEF and FEV1, patient satisfaction, medication side effects. At 2, 4, and 6 months: pain intensity, pain quality (neuropathic versus other), quality of life, pain interference with daily function

Detailed description: A total of 200 patients scheduled for lateral thoracotomy will be randomly assigned to receive either placebo or 150 mg pregabalin (Lyrica)1 hour prior to surgery, 12 hr after surgery and then every 12 hr for an additional 10 days. While in the hospital, patients will be assessed for pain intensity, satisfaction and side effects. Patients will be re-assessed at 2, 4 and 6 months following surgery.

Eligibility

Minimum age: 18 Years. Maximum age: 75 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Elective open thoracotomy for primary thoracic surgery, understanding and provision

of written informed consent, ASA class I II or III

Exclusion Criteria:

- Inability ot adhere to study protocol:

- intolerance or hypersensitivity to any agents to be used in the study,

contraindication to thoracic epidural placement

- inability to respond to the study questionnaire

- renal insufficiency(serum creatinine > 1. 5 upper limit of normal)

- Body Mass index > 40

- planned post-operative ventilation.

- Confounding procedural factors which might affect validity of data:

- previous ipsilateral thoracotomy

- surgery for tumor extending into the chest wall

- rest pain in proposed surgical area pre-operatively

- chest tube in situ at time of surgery

- requirement for second thoracotomy or re-occurrence of disease after surgery

*isolated pleuroscopy or pleurodesis procedures.

- Potential interaction with study medications and patient's current medications:

- current alcohol or other substance abuse

- chronic steroid use

- pre-existing chronic pain requiring chronic analgesic use

- history of seizure disorder requiring treatment with an anticonvulsant

- current therapy with thiazolidinedione class oral hypoglycemic agents (eg,

Actos, Avandia or Avandamet)

- history of congestive heart failure

- major psychiatric disorder

- any contraindication to use of NSAIDs.

- Insufficient safety data in the patient population:

- patients requiring preoperative assistance or assistive device for ambulation,

pregnant or breastfeeding

- weight <50 Kg

- dizziness while inpatient.

Locations and Contacts

Jorge E Zamora, MD, Phone: (613) 548-7827, Email: zamoraj@kgh.kair.net

Dr. Jorge E Zamora, Kingston, Ontario K7L 2V7, Canada
Additional Information

Starting date: January 2012
Last updated: July 15, 2011

Page last updated: December 08, 2011

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014